ACE and interstitial lung disease: In a univariate analysis, ACE levels were increased in patients with sarcoidosis, lymphoma (Hodgkin’s and non-Hodgkin’s), leukemia, cirrhosis, interstitial lung disease, Gaucher’s disease, hypertension, heart failure, and in those not taking ACE inhibitors.